Amplia Therapeutics Limited (ATX) is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. The company has a development focus in fibrotic cancers such as pancreatic and ovarian cancer. FAK also plays a role in chronic diseases, such as idiopathic pulmonary fibrosis (IPF).
Find out what a historical investment in Akora Resources would be worth today using our AKO stock calculator.
Buying AKO shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Akora Resources in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in AKO
What is the ticker symbol of Akora Resources?
The ticker symbol for Akora Resources is AKO.
How much is one share of AKO?
One share of AKO is valued at $0.08 as of 22 November 2026.
What is the market capitalisation of Akora Resources AKO?
As of 22 November 2026 Akora Resources has a market cap of $16.3M.
What is the P/E ratio of AKO?
The Price to Earnings ratio of AKO is -5.78.
What is the Earnings Per Share of AKO?
The Earnings Per Share of AKO is -$0.01.
What is the 52-week high for Akora Resources stock?
The Akora Resources 52-week high stock price is $0.11.
What is the 52-week low for Akora Resources stock?
The Akora Resources 52-week low stock price is $0.07.
Can I buy AKO shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy AKO shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.